Daily Technical Summary Reports on Healthcare Stocks -- Anthem, Centene, BioScrip, and Select Medical
NEW YORK, September 8, 2017 /PRNewswire/ --
If you want a Stock Review on ANTM, CNC, BIOS or SEM then come over to http://dailystocktracker.com/register/ and sign up for your free customized report. Today, DailyStockTracker.com observes the performance of Anthem Inc. (NYSE: ANTM), Centene Corp. (NYSE: CNC), BioScrip Inc. (NASDAQ: BIOS), and Select Medical Holdings Corp. (NYSE: SEM). Stocks in the Healthcare sector are often considered to be defensive, because their products and services are essential, according to an article on Investopedia. Even during economic downturns, people will still require medical aid and medicine to overcome illness. Having a consistent demand for goods and services makes this sector less sensitive to business cycle fluctuations. Register now and get full and free access to these DailyStockTracker.com research reports at:
http://dailystocktracker.com/register/
Anthem
On Thursday, shares in Indianapolis, Indiana headquartered Anthem Inc. recorded a trading volume of 1.16 million shares. The stock ended at $192.64, declining 0.52% from the last trading session. The Company's shares have gained 0.34% in the last one month, 2.69% over the previous three months, and 33.99% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 0.77% and 12.75%, respectively. Furthermore, shares of Anthem, which through its subsidiaries, operates as a health benefits company in the US, have a Relative Strength Index (RSI) of 48.68.
On August 31st, 2017, Anthem announced that senior management is scheduled to present at the Morgan Stanley Global Healthcare Conference on September 12th, 2017 at 9:10 a.m. EDT. A webcast of the presentation will be available under the "Investors" link of the Company's website. Access our complete research report on ANTM for free at:
http://dailystocktracker.com/registration/?symbol=ANTM
Centene
St. Louis, Missouri headquartered Centene Corp.'s stock finished yesterday's session 0.86% higher at $89.08 with a total trading volume of 845,704 shares. The Company's shares have gained 7.69% in the last one month, 14.69% over the previous three months, and 57.64% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 6.84% and 23.66%, respectively. Furthermore, shares of Centene, which operates as a diversified and multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the US, have an RSI of 71.90.
On August 29th, 2017, Centene announced that it will present at the Morgan Stanley Global Healthcare Conference, to be held from September 11th, 2017, to September 13th, 2017, at The Grand Hyatt in New York City. The Company is scheduled to present on September 12th, 2017, at 8:35 a.m. ET. The complimentary research report on CNC can be downloaded at:
http://dailystocktracker.com/registration/?symbol=CNC
BioScrip
At the close of trading on Thursday, shares in Denver, Colorado-based BioScrip Inc. saw a drop of 2.74%, ending the day at $2.84. The stock recorded a trading volume of 4.60 million shares, which was above its three months average volume of 1.53 million shares. The Company's shares have advanced 2.53% in the last one month, 22.94% in the previous three months, and 173.08% since the start of this year. The stock is trading 46.25% above its 200-day moving average. Moreover, shares of BioScrip, which provides home infusion services in the US, have an RSI of 45.64.
On August 10th, 2017, research firm SunTrust upgraded the Company's stock rating from 'Hold' to 'Buy'. Register for free on DailyStockTracker.com and get access to the latest report on BIOS at:
http://dailystocktracker.com/registration/?symbol=BIOS
Select Medical Holdings
Mechanicsburg, Pennsylvania headquartered Select Medical Holdings Corp.'s shares ended the day 0.54% lower at $18.25. A total volume of 900,496 shares was traded, which was above their three months average volume of 738,960 shares. The stock has gained 2.53% in the last month, 29.89% over the previous three months, and 37.74% on an YTD basis. The Company's shares are trading 9.98% above their 50-day moving average and 27.79% above their 200-day moving average. Additionally, shares of Select Medical, which through its subsidiary, Select Medical Corporation, operates specialty hospitals, outpatient rehabilitation clinics, and occupational medicine centers in the US, have an RSI of 64.28.
On August 15th, 2017, Select Medical Corporation, a wholly-owned subsidiary of Select Medical Holdings, announced that it will open a new, long-term acute care hospital within Missouri Baptist Medical Center in St. Louis, Missouri. The 38-bed facility, named Select Specialty Hospital - Town and Country, will be located on the 5th floor of Missouri Baptist's Main Tower and is anticipated to begin taking patients in the first quarter of 2018. Download your free research report on SEM at:
http://dailystocktracker.com/registration/?symbol=SEM
--
Daily Stock Tracker:
Daily Stock Tracker (DST) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. DST has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
DST has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email [email protected]. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by DST. DST is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
NO WARRANTY
DST, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. DST, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, DST, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither DST nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
http://dailystocktracker.com/disclaimer/
CONTACT
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Email: [email protected]
Phone number: (207)-331-3313
Office Address: 377 Rivonia Boulevard, Rivonia, South Africa
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE dailystocktracker.com
Share this article